Evox Therapeutics Company

Naturally inspired. Engineered to deliver. Transformative exosome therapeutics About Us Evox’s mission is to build a platform-driven technology company to spearhead the development of exosome therapeutics for the treatment of serious, life-threatening rare diseases where there are currently limited treatment options for patients and their families. Read More Pipeline Evox is developing an internal and ... Read more

Total Funding: £47.2M
Headquarters: Oxford, Oxfordshire, United Kingdom
Funding Status: Late Stage Venture
Employee Number: 51-100
Estimated Revenue: $10M to $50M
Investment Stage: Grant
Last Funding Type: Grant
Number Of Exists: Grant
Technology: Data-driven Technologies
Investor Type: Company
Investors Number: 9
Founded Date: 2016
Industry: PharmTech